Via Zoom. Speaker: Rikard Landberg, Professor at Food and Nutrition Science, Department of Biology and Biological Engineering, Chalmers University if Technology.
Zoom link: https://chalmers.zoom.us/j/67888472052
Abstract: The driving force behind the current global epidemic of obesity and type 2 diabetes is poor lifestyle. Dietary factors, physical inactivity, and sedentary behaviors are the major modifiable risk factors for obesity. Nevertheless, many overweight/obese people do not develop diabetes and lifestyle interventions focused on weight loss and diabetes prevention are often ineffective. Simple measurements of established clinical risk factors may not detect risk groups at an early stage or responders of treatment. The emergence of biomarker technologies has allowed more targeted therapeutic strategies for non-communicable disease prevention (precision medicine), though largely confined to pharmacotherapy. Unlike most drugs, lifestyle interventions often have systemic health-enhancing effects. Thus, the pursuance of lifestyle precision medicine in diseases such as type 2 diabetes, obesity and cardiovascular diseases appears rational and attractive. In this lecture, I will introduce precision prevention and how such concepts could look like by giving examples of ongoing and recently conducted international studies. I will put emphasis on the role of diet and personalized dietary strategies. Challenges impeding the clinical translation of lifestyle precision medicine will be discussed.
Contact: firstname.lastname@example.org, email@example.com
Cost: The seminar is free of charge and is arranged by Gothenburg ResearchSschool of Health Engineering (https://www.chalmers.se/en/areas-of-advance/health/external-collaboration/Gothenburg-Research-School-of-Health-Engineering/Pages/default.aspx)
Target group: PhD student and other researchers at Chalmers, Sahlgrenska Academy at Gothenburg University and Sahlgrenska University Hospital working with health and engineering.